These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37006282)

  • 1. Pan-Cancer analysis and experimental validation identify the oncogenic nature of ESPL1: Potential therapeutic target in colorectal cancer.
    Zhong Y; Zheng C; Zhang W; Wu H; Wang M; Zhang Q; Feng H; Wang G
    Front Immunol; 2023; 14():1138077. PubMed ID: 37006282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of ESPL1 is associated with poor prognostic outcomes in endometrial cancer.
    Yang Y; Sheng Y; Zheng J; Ma A; Chen S; Lin J; Yang X; Liang Y; Zhang Y; Zheng X
    Biomarkers; 2024 Jun; 29(4):185-193. PubMed ID: 38568742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology and insights into the role of cohesin protease separase in human malignancies.
    Zhang N; Pati D
    Biol Rev Camb Philos Soc; 2017 Nov; 92(4):2070-2083. PubMed ID: 28177203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Rate of Detection of Human ESPL1-HBV S Fusion Gene in Patients With HBV-related Liver Cancer: A Chinese Case-Control Study.
    Hu B; Huang W; Wang R; Zang W; Su M; Li H; Wang H; Cao B; Deng D; Li QQ; Jiang J
    Anticancer Res; 2020 Jan; 40(1):245-252. PubMed ID: 31892573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extra Spindle Pole Bodies-Like 1 Serves as a Prognostic Biomarker and Promotes Lung Adenocarcinoma Metastasis.
    Nie Z; Pu T; Han Z; Wang C; Pan C; Li P; Ma X; Yao Y; Zhao Y; Wang C; Jiang X; Ding J
    Front Oncol; 2022; 12():930647. PubMed ID: 35814478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESPL1 is a candidate oncogene of luminal B breast cancers.
    Finetti P; Guille A; Adelaide J; Birnbaum D; Chaffanet M; Bertucci F
    Breast Cancer Res Treat; 2014 Aug; 147(1):51-9. PubMed ID: 25086634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separase loss of function cooperates with the loss of p53 in the initiation and progression of T- and B-cell lymphoma, leukemia and aneuploidy in mice.
    Mukherjee M; Ge G; Zhang N; Huang E; Nakamura LV; Minor M; Fofanov V; Rao PH; Herron A; Pati D
    PLoS One; 2011; 6(7):e22167. PubMed ID: 21799785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The upregulation and transcriptional regulatory mechanisms of Extra spindle pole bodies like 1 in bladder cancer: An immunohistochemistry and high-throughput screening Evaluation.
    Zhang W; Liang ZQ; He RQ; Huang ZG; Wang XM; Wei MY; Su HL; Liu ZS; Zheng YS; Huang WY; Zhang HJ; Dang YW; Li SH; Cheng JW; Chen G; He J
    Heliyon; 2024 May; 10(10):e31192. PubMed ID: 38813236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma.
    Liu Z; Lian X; Zhang X; Zhu Y; Zhang W; Wang J; Wang H; Liu B; Ren Z; Zhang M; Liu M; Gao Y
    Front Genet; 2021; 12():666106. PubMed ID: 34512713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESPL1 is Elevated in Hepatocellular Carcinoma and Predicts Prognosis.
    Song R; Huang J; Yang C; Li Y; Zhan G; Xiang B
    Int J Gen Med; 2022; 15():8381-8398. PubMed ID: 36465268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer.
    Yang Q; Yu B; Sun J
    Biomed Res Int; 2020; 2020():4625123. PubMed ID: 33282948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Let-7c-5p Restrains Cell Growth and Induces Apoptosis of Lung Adenocarcinoma Cells via Targeting ESPL1.
    Liu X; Zeng W; Zheng D; Tang M; Zhou W
    Mol Biotechnol; 2022 Dec; 64(12):1367-1375. PubMed ID: 35639278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMTV-Espl1 transgenic mice develop aneuploid, estrogen receptor alpha (ERĪ±)-positive mammary adenocarcinomas.
    Mukherjee M; Ge G; Zhang N; Edwards DG; Sumazin P; Sharan SK; Rao PH; Medina D; Pati D
    Oncogene; 2014 Nov; 33(48):5511-5522. PubMed ID: 24276237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-cancer analysis identifies migrasome-related genes as a potential immunotherapeutic target: A bulk omics research and single cell sequencing validation.
    Qin Y; Yang J; Liang C; Liu J; Deng Z; Yan B; Fu Y; Luo Y; Li X; Wei X; Li W
    Front Immunol; 2022; 13():994828. PubMed ID: 36405728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum ESPL1 Can Be Used as a Biomarker for Patients With Hepatitis B Virus-Related Liver Cancer: A Chinese Case-Control Study.
    Wang R; Zang W; Hu B; Deng D; Ling X; Zhou H; Su M; Jiang J
    Technol Cancer Res Treat; 2020; 19():1533033820980785. PubMed ID: 33308056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the Timeless Gene with Prognosis and Clinical Characteristics of Human Lung Cancer.
    Ye J; Chen J; Wang J; Xia Z; Jia Y
    Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36359523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide CRISPR screen identifies ESPL1 limits the response of gastric cancer cells to apatinib.
    Zhang B; Chen Y; Chen X; Ren Z; Xiang H; Mao L; Zhu G
    Cancer Cell Int; 2024 Feb; 24(1):83. PubMed ID: 38402402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-cancer analysis: SPAG5 is an immunological and prognostic biomarker for multiple cancers.
    Gao X; Bu H; Gao X; Wang Y; Wang L; Zhang Z
    FASEB J; 2023 Oct; 37(10):e23159. PubMed ID: 37650687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Characteristics, Oncogenic Roles, and Relevant Immune and Pharmacogenomic Features of EVA1B in Colorectal Cancer.
    Ma B; Wang K; Liang Y; Meng Q; Li Y
    Front Immunol; 2022; 13():809837. PubMed ID: 35250982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of aberrantly methylated differentially expressed genes and associated pathways in endometrial cancer using integrated bioinformatic analysis.
    Liu J; Wan Y; Li S; Qiu H; Jiang Y; Ma X; Zhou S; Cheng W
    Cancer Med; 2020 May; 9(10):3522-3536. PubMed ID: 32170852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.